Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Drops for Recovery After Septoplasty
ChiCTR2300073335Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in deviated nasal septum (DNS) (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Quality of recovery-15 (QoR-15) postoperative recovery quality score. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
deviated nasal septum (DNS)
Beyond the preview
Go deeper on ChiCTR2300073335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073335.